ARCA biopharma Provides Business Update

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BROOMFIELD, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today provided a general business update and clinical development guidance.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC